The official action indicated classification for the Dadra unit by FDA follows similar trouble at Sun Pharma's Halol and ... analysts have said Advisory Alert: It has come to our attention that ...
New Delhi: On 18 April, Mumbai-headquartered Marksans Pharma, a drugmaker that ... from ThePrint on the status of this alert, the US FDA said that “in order for FDA to consider removing a product ...
In this note, we explored the specialty pipeline of SUNP, examining products under development, the commercialized portfolio, and the competitive dynamics within each segment. The overall R&D ...
Medtech startup EzeRx Health Tech Pvt Ltd, which counts drugmaker Sun Pharma as its largest investor, is in talks with at least two venture capital firms and a state-run company to raise fresh equity ...
NEW YORK and VIENNA, Austria, April 24, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ ... from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application ...
With its submission of a Pre-IND Meeting Request Letter, Innocan initiates the regulatory process with the U.S. Food and Drug Administration (FDA ... Innocan Pharma Corporation (CSE: INNO ...
Innocan initiates the regulatory process with the U.S. Food and Drug Administration (FDA) for the approval of its prolonged CBD release technology for human use HERZLIYA, Israel and CALGARY, AB, April ...
BRAF gene fusions are much more prevalent than BRAF V600 mutations, Day One’s head of R&D, Samuel Blackman, M.D., Ph.D., told Fierce Pharma in an interview ahead of the FDA approval. Samuel ...
Now read: CBD-Focused Pharma Co. Innocan Reveals 433% YoY Increase In 2023 Revenue As It Pursues FDA Approval ...
With its submission of a Pre-IND Meeting Request Letter, Innocan initiates the regulatory process with the U.S. Food and Drug Administration (FDA) for the approval of its prolonged CBD release ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results